Canadian Society of Intestinal Research (CSiR) The Canadian Society of Intestinal Research (CSiR) is a registered non-profit organization. Established on October 18, 1976, CSiR is dedicated to increasing public awareness, providing patient educational materials, spearheading patient advocacy, and funding medical research regarding all areas of the gastrointestinal tract – from reflux disease, to inflammatory bowel […]
GI Motility Testing: At a Glance Often the diagnosis of a functional GI disorder can be made with few or no tests. Sometimes tests are needed to rule out another disease. Usually some preparation is needed before the test may be done. Correct preparation for a test helps make it easier and more effective. Knowing […]
Fundraise for Digestive Health “Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has.” — Margaret Mead If you or someone you know has a chronic digestive disorder, you are not alone. Millions of people of all ages know the profound effect […]
Behavioral Treatments for Gastrointestinal Disorders Presented by Laurie Keefer, PhD Dr. Laurie Keefer Watch presentation here Presentation Overview: Why do we use behavioral therapies in the management of GI conditions? There are two primary reasons why behavioral therapies are often used in GI conditions. First, GI disorders do not happen in a vacuum- they can affect our […]
Constipation remains one of the most common intestinal problems affecting children – and a source of bewilderment and worry for many parents. Fortunately, most constipation in infants and children is not caused by any serious underlying medical disease. The challenge, therefore, is for parents to manage constipation, guided by an understanding of why their child […]
News Article
For Immediate Release Media Contact Formdocument.getElementById(‘cloaka1498a5e4e09dce9d42dca753c7a045b’).innerHTML = ”;var prefix = ‘ma’ + ‘il’ + ‘to’;var path = ‘hr’ + ‘ef’ + ‘=’;var addya1498a5e4e09dce9d42dca753c7a045b = ‘media’ + ‘@’;addya1498a5e4e09dce9d42dca753c7a045b = addya1498a5e4e09dce9d42dca753c7a045b + ‘iffgd’ + ‘.’ + ‘org?subject=Media%20Inquiry’;var addy_texta1498a5e4e09dce9d42dca753c7a045b = ‘Media Contact Form’;document.getElementById(‘cloaka1498a5e4e09dce9d42dca753c7a045b’).innerHTML += ‘‘+addy_texta1498a5e4e09dce9d42dca753c7a045b+’‘; IFFGD 414-964-1799 MOUNT PLEASANT, SC (March 28, 2019) — For the 30 to 45 […]
News Article
IFFGD’s IBS Patients’ Illness Experience and Unmet Needs Survey International Foundation for Gastrointestinal Disorders (IFFGD) reimplements this survey to assess the illness experience and unmet needs of patients with irritable bowel syndrome (IBS). Media Contact Formdocument.getElementById(‘cloake84ea5433897da912fb9064204db6bc9’).innerHTML = ”;var prefix = ‘ma’ + ‘il’ + ‘to’;var path = ‘hr’ + ‘ef’ + ‘=’;var addye84ea5433897da912fb9064204db6bc9 = ‘media’ […]
Testimony
The following written comments were submitted by IFFGD president, Ceciel T. Rooker, to the US Department of Defense (DoD) in connection with a January 10, 2019 meeting of the TRICARE Beneficiary Advisory Panel (BAP) regarding the Uniform Formulary and, specifically, review of gastrointestinal agents: The International Foundation for Gastrointestinal Disorders (IFFGD) commends TRICARE and the […]
Testimony
On June 26, 2000, IFFGD Founder and President Nancy J. Norton presented the following testimony on behalf of IFFGD members to the Center for Drug Evaluation and Research, Gastrointestinal Drugs Advisory Committee regarding (NDA) 21-200, Zelnorm/Zelmac (tegaserod), produced by Novartis Pharmaceuticals Corporation: Before I begin, I would just like to say that I am here […]
Testimony
IFFGD Founder and President, Nancy Norton, submitted the following written statement to the House Committee on Appropriations; Subcommittee on Labor, Health and Human Services, Education and Related Agencies regarding Fiscal Year 2010 appropriations for the National Institutes of Health on May 1, 2009: Thank you for the opportunity to present this written statement regarding the […]
Testimony
Nancy J. Norton, President and Co-Founder of IFFGD submitted the following written statement regarding Fiscal Year 2009 appropriations for the National Institutes of Health to the Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies on April 28, 2008: Thank you for the opportunity to present this written statement […]
By: G. Richard Locke III, M.D., Associate Professor of Medicine, Mayo Medical School, Rochester, MN Over the past several years, healthcare professionals have become increasingly interested in gastroesophageal reflux disease (GERD) because of its prevalence and impact on the community. This heightened focus can be attributed to several factors – GERD is a common problem […]